5-((5-methyl-3-thienyl)oxy)-2(1h)-pyrimidinone has been researched along with Pregnancy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kane, SC; Stewart, B; Unterscheider, J | 1 |
1 other study(ies) available for 5-((5-methyl-3-thienyl)oxy)-2(1h)-pyrimidinone and Pregnancy
| Article | Year |
|---|---|
Medical termination of pregnancy for fetal anomaly at or beyond 20 weeks' gestation-What are the maternal risks?
Topics: Cesarean Section; Female; Gestational Age; Humans; Placenta; Pregnancy; Retrospective Studies | 2022 |